INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K

Form 4 transactions

18,675 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
30
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.26M
12.7K sh
Jun 24, 2026Jun 26, 2026
Page 186 of 467
← PrevNext →
traded Jun 24, 2026
+2d
SEC Form 4

Evidence

30
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.64M
16.2K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

29
SE
Smolyansky Edward10% Owner
LWAYLifeway Foods, Inc.
Open-market sale
SELL$55K
1,793 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

28
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$62K
602 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

28
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$250K
2,410 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

27
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$410K
4,062 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

27
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$962K
9,445 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

27
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$316K
3,167 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

27
WP
Wierbicki PaulDirector, Chief Legal Officer
RSIRush Street Interactive, Inc.
Open-market sale
SELL$301K
10.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

27
BL
Burrows Scott LChief Financial Officer
SYRESpyre Therapeutics, Inc.
Open-market sale
SELL$871K
10.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

26
ST
Smokoff TimothyDirector
VMDVIEMED HEALTHCARE, INC.
Open-market sale
SELL$19K
1,636 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

26
ST
Smokoff TimothyDirector
VMDVIEMED HEALTHCARE, INC.
Open-market sale
SELL$39K
3,364 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

25
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$4,178
40 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

25
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$17K
160 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

24
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$241K
2,362 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

23
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$411K
4,160 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

23
PA
Pande AtulDirector
IMVTImmunovant, Inc.
Open-market sale · 10b5-1 plan
SELL$57K
1,500 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

23
BL
Burrows Scott LChief Financial Officer
SYRESpyre Therapeutics, Inc.
Open-market sale
SELL$436K
5,000 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

22
DD
Dockery Derrick D.Director
TLSTELOS CORP
Open-market sale
SELL$31K
7,000 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

22
SR
Sakakibara Shan RikuChief Product Officer
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$440K
4,000 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

22
AI
Alclear Investments, LLCDirector, 10% Owner, See Remarks
YOUClear Secure, Inc.
Open-market sale · 10b5-1 plan
SELL$1.82M
34.3K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

22
SR
Sakakibara Shan RikuChief Product Officer
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$440K
4,000 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

21
CN
Chandhok NikhilChief Product & Tech. Officer
CRCLCircle Internet Group, Inc.
Open-market sale · 10b5-1 plan
SELL$13.72M
188.6K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

20
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$103K
1,040 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

19
TC
Thomas John CharlesEVP, General Counsel
KRYSKrystal Biotech, Inc.
Open-market sale · 10b5-1 plan
SELL$347K
1,000 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

19
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$403K
1,279 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

19
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$890K
2,854 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

19
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$264K
837 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

18
SJ
Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER
LTHLife Time Group Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$2.62M
67.8K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

18
GD
Graff Marc D.SVP & Chief Financial Officer
CIENCIENA CORP
Open-market sale · 10b5-1 plan
SELL$57K
126 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

17
HJ
Hogan Michael JamesChief Strategy Officer
GFSGLOBALFOUNDRIES Inc.
Open-market sale · 10b5-1 plan
SELL$234K
2,800 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

16
RD
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$4.06M
16.2K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

16
RD
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$2.82M
11.1K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

16
LR
Lewis Michelle ReneeChief Accounting Officer
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$600K
15.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

16
VA
Verma AbhimanyuChief Technology Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$38K
6,944 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

15
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$544K
1,750 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

15
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$314K
1,004 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

15
CH
Colson Nathaniel HOfficer EVP, CFO & CRO
MTGMGIC INVESTMENT CORP
Open-market sale · 10b5-1 plan
SELL$542K
20.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

15
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$309K
999 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

15
GT
Galla Christopher TSVP, GC, and Corp. Secretary
GPCGENUINE PARTS CO
Open-market sale · 10b5-1 plan
SELL$268K
2,333 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence